| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Vakiener Victoria is a Director at ARROWHEAD PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 10,040 | $67.68 | $679,491.34 | -7.9% | -16.4% | - | |
| Dec 16, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 8,994 | $21.91 | $197,058.54 | -29.8% | -30.3% | +189.0% | |
| May 2, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 1,799 | $23.31 | $41,934.69 | -5.6% | +18.4% | -40.2% | |
| Jan 11, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 4,720 | $38.10 | $179,813.40 | -6.8% | -32.3% | -50.7% | |
| Sep 28, 2023 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 1,550 | $26.33 | $40,811.50 | -6.7% | +15.2% | -27.0% |